SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4c0d'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1A28_A_STRA1_1 (PROGESTERONE RECEPTOR)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	5 / 12	LEU A2218 LEU A2214 LEU A2184 THR A2224 PHE A2168	None	1.40A	1a28A-4c0dA: undetectable	1a28A-4c0dA: 14.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DZ6_A_CAMA502_0 (CYTOCHROME P450-CAM)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 5	PHE A1985 LEU A2026 VAL A1907 ASP A1977	None	1.33A	1dz6A-4c0dA: undetectable	1dz6A-4c0dA: 19.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1N13_D_AG2D7015_1 (PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE ALPHA CHAIN PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE BETA CHAIN)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1901 GLU A1850 ARG A1900 ASP A1844	None	0.66A	1n13D-4c0dA: undetectable 1n13E-4c0dA: undetectable	1n13D-4c0dA: 9.33 1n13E-4c0dA: 4.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ONI_A_BEZA502_0 (14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	ASN A2216 ASN A2272 ARG A2311 ILE A2121	None	1.02A	1oniA-4c0dA: undetectable 1oniB-4c0dA: 2.0	1oniA-4c0dA: 10.80 1oniB-4c0dA: 10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ONI_D_BEZD508_0 (14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	ASN A2216 ASN A2272 ARG A2311 ILE A2121	None	1.07A	1oniD-4c0dA: undetectable 1oniF-4c0dA: undetectable	1oniD-4c0dA: 10.80 1oniF-4c0dA: 10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q13_A_TESA501_1 (PROSTAGLANDIN-E2 9-REDUCTASE)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3 (Homo sapiens)	4 / 6	TYR C 613 HIS A1978 PRO A2087 VAL A2035	None	1.34A	1q13A-4c0dC: undetectable	1q13A-4c0dC: 19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_C_CHDC3271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE III CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 8	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.84A	1v54C-4c0dA: 2.5 1v54J-4c0dA: undetectable	1v54C-4c0dA: 14.62 1v54J-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_C_CHDC3271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE III CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 8	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.89A	1v54C-4c0dA: 2.5 1v54J-4c0dA: undetectable	1v54C-4c0dA: 14.62 1v54J-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V55_C_CHDC3271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE III CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.85A	1v55C-4c0dA: 2.5 1v55J-4c0dA: undetectable	1v55C-4c0dA: 14.62 1v55J-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V55_C_CHDC3271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE III CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.96A	1v55C-4c0dA: 2.5 1v55J-4c0dA: undetectable	1v55C-4c0dA: 14.62 1v55J-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 8	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.82A	2dyrC-4c0dA: 2.5 2dyrJ-4c0dA: undetectable	2dyrC-4c0dA: 14.62 2dyrJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 8	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.89A	2dyrC-4c0dA: 2.5 2dyrJ-4c0dA: undetectable	2dyrC-4c0dA: 14.62 2dyrJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 8	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.92A	2dyrP-4c0dA: 2.6 2dyrW-4c0dA: undetectable	2dyrP-4c0dA: 14.62 2dyrW-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_C_CHDC310_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.93A	2dysC-4c0dA: 2.5 2dysJ-4c0dA: undetectable	2dysC-4c0dA: 14.62 2dysJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_C_CHDC310_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.89A	2dysC-4c0dA: 2.5 2dysJ-4c0dA: undetectable	2dysC-4c0dA: 14.62 2dysJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_P_CHDP310_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.99A	2dysP-4c0dA: 2.6 2dysW-4c0dA: undetectable	2dysP-4c0dA: 14.62 2dysW-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.86A	2eijC-4c0dA: 2.6 2eijJ-4c0dA: undetectable	2eijC-4c0dA: 14.62 2eijJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.94A	2eijC-4c0dA: 2.6 2eijJ-4c0dA: undetectable	2eijC-4c0dA: 14.62 2eijJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.97A	2eijP-4c0dA: 2.6 2eijW-4c0dA: undetectable	2eijP-4c0dA: 14.62 2eijW-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.87A	2eikC-4c0dA: 2.6 2eikJ-4c0dA: undetectable	2eikC-4c0dA: 14.62 2eikJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.96A	2eikC-4c0dA: 2.6 2eikJ-4c0dA: undetectable	2eikC-4c0dA: 14.62 2eikJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 8	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.87A	2eilC-4c0dA: 2.6 2eilJ-4c0dA: undetectable	2eilC-4c0dA: 14.62 2eilJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.89A	2eimC-4c0dA: 3.1 2eimJ-4c0dA: undetectable	2eimC-4c0dA: 14.62 2eimJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIM_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.95A	2eimC-4c0dA: 3.1 2eimJ-4c0dA: undetectable	2eimC-4c0dA: 14.62 2eimJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.94A	2einC-4c0dA: 3.0 2einJ-4c0dA: undetectable	2einC-4c0dA: 14.62 2einJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.96A	2einC-4c0dA: 3.0 2einJ-4c0dA: undetectable	2einC-4c0dA: 14.62 2einJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.88A	2einP-4c0dA: 2.8 2einW-4c0dA: undetectable	2einP-4c0dA: 14.62 2einW-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDB_A_NPSA1591_1 (SERUM ALBUMIN)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 8	ILE A2242 PHE A2251 PHE A2284 GLY A2223	None	0.70A	2vdbA-4c0dA: 0.0	2vdbA-4c0dA: 21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VUF_B_FUAB2002_1 (SERUM ALBUMIN)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 9	ILE A1993 ARG A1992 ALA A1938 VAL A1940	None	0.98A	2vufB-4c0dA: 2.5	2vufB-4c0dA: 21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.81A	2zxwC-4c0dA: 2.5 2zxwJ-4c0dA: undetectable	2zxwC-4c0dA: 14.62 2zxwJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.90A	2zxwC-4c0dA: 2.5 2zxwJ-4c0dA: undetectable	2zxwC-4c0dA: 14.62 2zxwJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.92A	2zxwP-4c0dA: 2.6 2zxwW-4c0dA: undetectable	2zxwP-4c0dA: 14.62 2zxwW-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.93A	2zxwP-4c0dA: 2.6 2zxwW-4c0dA: undetectable	2zxwP-4c0dA: 14.62 2zxwW-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABL_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 5	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.93A	3ablC-4c0dA: 4.2 3ablJ-4c0dA: undetectable	3ablC-4c0dA: 14.62 3ablJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABL_P_CHDP1271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	1.04A	3ablP-4c0dA: 2.5 3ablW-4c0dA: undetectable	3ablP-4c0dA: 14.62 3ablW-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG1_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.94A	3ag1C-4c0dA: 3.0 3ag1J-4c0dA: undetectable	3ag1C-4c0dA: 14.62 3ag1J-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG1_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.85A	3ag1C-4c0dA: 3.0 3ag1J-4c0dA: undetectable	3ag1C-4c0dA: 14.62 3ag1J-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_C_CHDC271_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 8	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.91A	3ag4C-4c0dA: 2.5 3ag4J-4c0dA: undetectable	3ag4C-4c0dA: 14.62 3ag4J-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_C_CHDC271_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.90A	3asnC-4c0dA: 4.3 3asnJ-4c0dA: undetectable	3asnC-4c0dA: 14.62 3asnJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_C_CHDC271_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.93A	3asnC-4c0dA: 4.3 3asnJ-4c0dA: undetectable	3asnC-4c0dA: 14.62 3asnJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CR5_X_PNTX95_0 (PROTEIN S100-B)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	3 / 3	CYH A2020 PHE A2019 PHE A2023	None	0.98A	3cr5X-4c0dA: undetectable	3cr5X-4c0dA: 8.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4B9Z_A_ACRA1818_1 (ALPHA-GLUCOSIDASE, PUTATIVE, ADG31B)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	5 / 12	ASP A1893 LEU A1894 LEU A1901 ARG A1900 ASP A1843	None	1.13A	4b9zA-4c0dA: 2.7	4b9zA-4c0dA: 23.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4GRK_A_KTRA713_1 (LACTOTRANSFERRIN)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3 (Homo sapiens)	4 / 5	GLY A2033 VAL A2035 PRO A2032 TYR C 613	None	1.07A	4grkA-4c0dA: undetectable	4grkA-4c0dA: 17.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4HTF_A_ACTA303_0 (S-ADENOSYLMETHIONINE -DEPENDENT METHYLTRANSFERASE)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	3 / 3	TYR A2276 HIS A2114 ARG A2275	None	0.82A	4htfA-4c0dA: undetectable	4htfA-4c0dA: 17.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OKX_A_198A1002_2 (ANDROGEN RECEPTOR)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	LEU A2267 ASN A2268 LEU A2308 ILE A2126	None	1.14A	4okxA-4c0dA: undetectable	4okxA-4c0dA: 14.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA0_A_SHHA404_2 (HISTONE DEACETYLASE 8)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3 (Homo sapiens)	3 / 3	PRO C 626 MET C 625 TYR A2036	None	1.11A	4qa0B-4c0dC: undetectable	4qa0B-4c0dC: 16.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QA0_B_SHHB404_1 (HISTONE DEACETYLASE 8)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3 (Homo sapiens)	3 / 3	PRO C 626 MET C 625 TYR A2036	None	1.09A	4qa0A-4c0dC: undetectable	4qa0A-4c0dC: 16.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XLD_A_BRLA502_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	5 / 12	PHE A2023 CYH A2020 PHE A2047 MET A2051 LEU A1967	None	1.27A	4xldA-4c0dA: undetectable	4xldA-4c0dA: 16.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	1.00A	5b1bC-4c0dA: 2.5 5b1bJ-4c0dA: undetectable	5b1bC-4c0dA: 14.62 5b1bJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.85A	5b1bP-4c0dA: 2.5 5b1bW-4c0dA: undetectable	5b1bP-4c0dA: 14.62 5b1bW-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.98A	5b1bP-4c0dA: 2.5 5b1bW-4c0dA: undetectable	5b1bP-4c0dA: 14.62 5b1bW-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DNV_A_BEZA304_0 (SHKAI2IB)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 5	GLN A1882 HIS A1884 ILE A1888 TYR A1854	None	1.27A	5dnvA-4c0dA: undetectable	5dnvA-4c0dA: 17.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KM8_B_L8PB201_1 (HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 2, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 8	ASN A2272 ALA A2271 GLN A2273 HIS A2114	None	1.03A	5km8A-4c0dA: undetectable 5km8B-4c0dA: undetectable	5km8A-4c0dA: 11.81 5km8B-4c0dA: 11.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M45_A_ACTA803_0 (ACETONE CARBOXYLASE ALPHA SUBUNIT)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3 (Homo sapiens; Homo sapiens)	4 / 4	GLU C 618 PRO A2087 ILE A2090 LEU A2091	None	1.21A	5m45A-4c0dC: undetectable	5m45A-4c0dC: 12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M45_D_ACTD803_0 (ACETONE CARBOXYLASE ALPHA SUBUNIT)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3 (Homo sapiens; Homo sapiens)	4 / 4	GLU C 618 PRO A2087 ILE A2090 LEU A2091	None	1.22A	5m45D-4c0dC: undetectable	5m45D-4c0dC: 12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M45_G_ACTG803_0 (ACETONE CARBOXYLASE ALPHA SUBUNIT)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3 (Homo sapiens; Homo sapiens)	4 / 4	GLU C 618 PRO A2087 ILE A2090 LEU A2091	None	1.21A	5m45G-4c0dC: undetectable	5m45G-4c0dC: 12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M45_J_ACTJ803_0 (ACETONE CARBOXYLASE ALPHA SUBUNIT)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3 (Homo sapiens; Homo sapiens)	4 / 4	GLU C 618 PRO A2087 ILE A2090 LEU A2091	None	1.26A	5m45J-4c0dC: undetectable	5m45J-4c0dC: 12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1F_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3 (Homo sapiens)	4 / 5	LEU C 671 PHE C 673 LEU C 666 PHE C 662	None	1.13A	5x1fC-4c0dC: undetectable 5x1fJ-4c0dC: undetectable	5x1fC-4c0dC: 22.39 5x1fJ-4c0dC: 15.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XOO_B_ADNB503_1 (GLYCOSAMINOGLYCAN XYLOSYLKINASE)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3 (Homo sapiens)	4 / 5	LEU A2039 VAL A2035 GLU C 618 LEU A2091	None	1.03A	5xooB-4c0dA: undetectable	5xooB-4c0dA: 6.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y2O_A_8N6A501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	5 / 12	PHE A2023 CYH A2020 PHE A2047 MET A2051 LEU A1967	None	1.22A	5y2oA-4c0dA: undetectable	5y2oA-4c0dA: 7.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z84_P_CHDP305_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	1.03A	5z84P-4c0dA: 2.6 5z84W-4c0dA: undetectable	5z84P-4c0dA: 14.62 5z84W-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z85_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.94A	5z85C-4c0dA: 2.5 5z85J-4c0dA: undetectable	5z85C-4c0dA: 14.62 5z85J-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z85_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	1.04A	5z85P-4c0dA: 2.5 5z85W-4c0dA: undetectable	5z85P-4c0dA: 14.62 5z85W-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z86_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	1.00A	5z86C-4c0dA: 2.6 5z86J-4c0dA: undetectable	5z86C-4c0dA: 14.62 5z86J-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Z86_P_CHDP307_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	0.97A	5z86P-4c0dA: 2.6 5z86W-4c0dA: undetectable	5z86P-4c0dA: 14.62 5z86W-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCO_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.93A	5zcoC-4c0dA: 2.5 5zcoJ-4c0dA: undetectable	5zcoC-4c0dA: 14.62 5zcoJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCO_P_CHDP305_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	1.04A	5zcoP-4c0dA: 4.3 5zcoW-4c0dA: undetectable	5zcoP-4c0dA: 14.62 5zcoW-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCP_C_CHDC306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	1.06A	5zcpC-4c0dA: 2.6 5zcpJ-4c0dA: undetectable	5zcpC-4c0dA: 14.62 5zcpJ-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCP_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 6	GLN A2252 PHE A2251 LEU A2196 PHE A2192	None	1.07A	5zcpP-4c0dA: 2.6 5zcpW-4c0dA: undetectable	5zcpP-4c0dA: 14.62 5zcpW-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCQ_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	4 / 7	LEU A1975 GLN A1976 LEU A2026 PHE A2034	None	0.94A	5zcqP-4c0dA: 2.6 5zcqW-4c0dA: undetectable	5zcqP-4c0dA: 14.62 5zcqW-4c0dA: 5.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HUP_E_DZPE502_0 (GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT ALPHA-1,GAMMA-AMINOB UTYRIC ACID RECEPTOR SUBUNIT ALPHA-1 GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT BETA-3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	5 / 10	LEU A2016 LEU A1963 THR A2022 ASN A2021 MET A2063	None	1.42A	6hupD-4c0dA: 3.1 6hupE-4c0dA: 2.6	6hupD-4c0dA: 7.98 6hupE-4c0dA: 7.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HUP_E_DZPE502_0 (GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT ALPHA-1,GAMMA-AMINOB UTYRIC ACID RECEPTOR SUBUNIT ALPHA-1 GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT BETA-3)	4c0d	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	5 / 10	LEU A2016 LEU A1963 THR A2022 ASN A2021 PHE A2023	None	1.15A	6hupD-4c0dA: 3.1 6hupE-4c0dA: 2.6	6hupD-4c0dA: 7.98 6hupE-4c0dA: 7.50

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1A28_A_STRA1_1","PROGESTERONE RECEPTOR","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",5,"LEU A2218;LEU A2214;LEU A2184;THR A2224;PHE A2168","None","1.40A","1a28A-4c0dA:undetectable","1a28A-4c0dA:14.64"],["1DZ6_A_CAMA502_0","CYTOCHROME P450-CAM","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"PHE A1985;LEU A2026;VAL A1907;ASP A1977","None","1.33A","1dz6A-4c0dA:undetectable","1dz6A-4c0dA:19.95"],["1N13_D_AG2D7015_1","PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE ALPHA CHAIN;PYRUVOYL-DEPENDENT ARGININE DECARBOXYLASE BETA CHAIN","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1901;GLU A1850;ARG A1900;ASP A1844","None","0.66A","1n13D-4c0dA:undetectable;1n13E-4c0dA:undetectable","1n13D-4c0dA:9.33;1n13E-4c0dA:4.91"],["1ONI_A_BEZA502_0","14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"ASN A2216;ASN A2272;ARG A2311;ILE A2121","None","1.02A","1oniA-4c0dA:undetectable;1oniB-4c0dA:2.0","1oniA-4c0dA:10.80;1oniB-4c0dA:10.80"],["1ONI_D_BEZD508_0","14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"ASN A2216;ASN A2272;ARG A2311;ILE A2121","None","1.07A","1oniD-4c0dA:undetectable;1oniF-4c0dA:undetectable","1oniD-4c0dA:10.80;1oniF-4c0dA:10.80"],["1Q13_A_TESA501_1","PROSTAGLANDIN-E2 9-REDUCTASE","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1;CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3","Homo sapiens",4,"TYR C 613;HIS A1978;PRO A2087;VAL A2035","None","1.34A","1q13A-4c0dC:undetectable","1q13A-4c0dC:19.51"],["1V54_C_CHDC3271_0","CYTOCHROME C OXIDASE POLYPEPTIDE III;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.84A","1v54C-4c0dA:2.5;1v54J-4c0dA:undetectable","1v54C-4c0dA:14.62;1v54J-4c0dA:5.38"],["1V54_C_CHDC3271_0","CYTOCHROME C OXIDASE POLYPEPTIDE III;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.89A","1v54C-4c0dA:2.5;1v54J-4c0dA:undetectable","1v54C-4c0dA:14.62;1v54J-4c0dA:5.38"],["1V55_C_CHDC3271_0","CYTOCHROME C OXIDASE POLYPEPTIDE III;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.85A","1v55C-4c0dA:2.5;1v55J-4c0dA:undetectable","1v55C-4c0dA:14.62;1v55J-4c0dA:5.38"],["1V55_C_CHDC3271_0","CYTOCHROME C OXIDASE POLYPEPTIDE III;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.96A","1v55C-4c0dA:2.5;1v55J-4c0dA:undetectable","1v55C-4c0dA:14.62;1v55J-4c0dA:5.38"],["2DYR_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.82A","2dyrC-4c0dA:2.5;2dyrJ-4c0dA:undetectable","2dyrC-4c0dA:14.62;2dyrJ-4c0dA:5.38"],["2DYR_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.89A","2dyrC-4c0dA:2.5;2dyrJ-4c0dA:undetectable","2dyrC-4c0dA:14.62;2dyrJ-4c0dA:5.38"],["2DYR_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.92A","2dyrP-4c0dA:2.6;2dyrW-4c0dA:undetectable","2dyrP-4c0dA:14.62;2dyrW-4c0dA:5.38"],["2DYS_C_CHDC310_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.93A","2dysC-4c0dA:2.5;2dysJ-4c0dA:undetectable","2dysC-4c0dA:14.62;2dysJ-4c0dA:5.38"],["2DYS_C_CHDC310_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.89A","2dysC-4c0dA:2.5;2dysJ-4c0dA:undetectable","2dysC-4c0dA:14.62;2dysJ-4c0dA:5.38"],["2DYS_P_CHDP310_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.99A","2dysP-4c0dA:2.6;2dysW-4c0dA:undetectable","2dysP-4c0dA:14.62;2dysW-4c0dA:5.38"],["2EIJ_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.86A","2eijC-4c0dA:2.6;2eijJ-4c0dA:undetectable","2eijC-4c0dA:14.62;2eijJ-4c0dA:5.38"],["2EIJ_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.94A","2eijC-4c0dA:2.6;2eijJ-4c0dA:undetectable","2eijC-4c0dA:14.62;2eijJ-4c0dA:5.38"],["2EIJ_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.97A","2eijP-4c0dA:2.6;2eijW-4c0dA:undetectable","2eijP-4c0dA:14.62;2eijW-4c0dA:5.38"],["2EIK_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.87A","2eikC-4c0dA:2.6;2eikJ-4c0dA:undetectable","2eikC-4c0dA:14.62;2eikJ-4c0dA:5.38"],["2EIK_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.96A","2eikC-4c0dA:2.6;2eikJ-4c0dA:undetectable","2eikC-4c0dA:14.62;2eikJ-4c0dA:5.38"],["2EIL_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.87A","2eilC-4c0dA:2.6;2eilJ-4c0dA:undetectable","2eilC-4c0dA:14.62;2eilJ-4c0dA:5.38"],["2EIM_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.89A","2eimC-4c0dA:3.1;2eimJ-4c0dA:undetectable","2eimC-4c0dA:14.62;2eimJ-4c0dA:5.38"],["2EIM_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.95A","2eimC-4c0dA:3.1;2eimJ-4c0dA:undetectable","2eimC-4c0dA:14.62;2eimJ-4c0dA:5.38"],["2EIN_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.94A","2einC-4c0dA:3.0;2einJ-4c0dA:undetectable","2einC-4c0dA:14.62;2einJ-4c0dA:5.38"],["2EIN_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.96A","2einC-4c0dA:3.0;2einJ-4c0dA:undetectable","2einC-4c0dA:14.62;2einJ-4c0dA:5.38"],["2EIN_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.88A","2einP-4c0dA:2.8;2einW-4c0dA:undetectable","2einP-4c0dA:14.62;2einW-4c0dA:5.38"],["2VDB_A_NPSA1591_1","SERUM ALBUMIN","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"ILE A2242;PHE A2251;PHE A2284;GLY A2223","None","0.70A","2vdbA-4c0dA:0.0","2vdbA-4c0dA:21.61"],["2VUF_B_FUAB2002_1","SERUM ALBUMIN","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"ILE A1993;ARG A1992;ALA A1938;VAL A1940","None","0.98A","2vufB-4c0dA:2.5","2vufB-4c0dA:21.31"],["2ZXW_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.81A","2zxwC-4c0dA:2.5;2zxwJ-4c0dA:undetectable","2zxwC-4c0dA:14.62;2zxwJ-4c0dA:5.38"],["2ZXW_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.90A","2zxwC-4c0dA:2.5;2zxwJ-4c0dA:undetectable","2zxwC-4c0dA:14.62;2zxwJ-4c0dA:5.38"],["2ZXW_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.92A","2zxwP-4c0dA:2.6;2zxwW-4c0dA:undetectable","2zxwP-4c0dA:14.62;2zxwW-4c0dA:5.38"],["2ZXW_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.93A","2zxwP-4c0dA:2.6;2zxwW-4c0dA:undetectable","2zxwP-4c0dA:14.62;2zxwW-4c0dA:5.38"],["3ABL_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.93A","3ablC-4c0dA:4.2;3ablJ-4c0dA:undetectable","3ablC-4c0dA:14.62;3ablJ-4c0dA:5.38"],["3ABL_P_CHDP1271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","1.04A","3ablP-4c0dA:2.5;3ablW-4c0dA:undetectable","3ablP-4c0dA:14.62;3ablW-4c0dA:5.38"],["3AG1_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.94A","3ag1C-4c0dA:3.0;3ag1J-4c0dA:undetectable","3ag1C-4c0dA:14.62;3ag1J-4c0dA:5.38"],["3AG1_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.85A","3ag1C-4c0dA:3.0;3ag1J-4c0dA:undetectable","3ag1C-4c0dA:14.62;3ag1J-4c0dA:5.38"],["3AG4_C_CHDC271_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.91A","3ag4C-4c0dA:2.5;3ag4J-4c0dA:undetectable","3ag4C-4c0dA:14.62;3ag4J-4c0dA:5.38"],["3ASN_C_CHDC271_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.90A","3asnC-4c0dA:4.3;3asnJ-4c0dA:undetectable","3asnC-4c0dA:14.62;3asnJ-4c0dA:5.38"],["3ASN_C_CHDC271_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.93A","3asnC-4c0dA:4.3;3asnJ-4c0dA:undetectable","3asnC-4c0dA:14.62;3asnJ-4c0dA:5.38"],["3CR5_X_PNTX95_0","PROTEIN S100-B","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",3,"CYH A2020;PHE A2019;PHE A2023","None","0.98A","3cr5X-4c0dA:undetectable","3cr5X-4c0dA:8.64"],["4B9Z_A_ACRA1818_1","ALPHA-GLUCOSIDASE, PUTATIVE, ADG31B","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",5,"ASP A1893;LEU A1894;LEU A1901;ARG A1900;ASP A1843","None","1.13A","4b9zA-4c0dA:2.7","4b9zA-4c0dA:23.25"],["4GRK_A_KTRA713_1","LACTOTRANSFERRIN","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1;CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3","Homo sapiens",4,"GLY A2033;VAL A2035;PRO A2032;TYR C 613","None","1.07A","4grkA-4c0dA:undetectable","4grkA-4c0dA:17.49"],["4HTF_A_ACTA303_0","S-ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASE","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",3,"TYR A2276;HIS A2114;ARG A2275","None","0.82A","4htfA-4c0dA:undetectable","4htfA-4c0dA:17.49"],["4OKX_A_198A1002_2","ANDROGEN RECEPTOR","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A2267;ASN A2268;LEU A2308;ILE A2126","None","1.14A","4okxA-4c0dA:undetectable","4okxA-4c0dA:14.95"],["4QA0_A_SHHA404_2","HISTONE DEACETYLASE 8;HISTONE DEACETYLASE 8","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1;CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3","Homo sapiens",3,"PRO C 626;MET C 625;TYR A2036","None","1.11A","4qa0B-4c0dC:undetectable","4qa0B-4c0dC:16.58"],["4QA0_B_SHHB404_1","HISTONE DEACETYLASE 8;HISTONE DEACETYLASE 8","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1;CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3","Homo sapiens",3,"PRO C 626;MET C 625;TYR A2036","None","1.09A","4qa0A-4c0dC:undetectable","4qa0A-4c0dC:16.58"],["4XLD_A_BRLA502_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",5,"PHE A2023;CYH A2020;PHE A2047;MET A2051;LEU A1967","None","1.27A","4xldA-4c0dA:undetectable","4xldA-4c0dA:16.83"],["5B1B_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","1.00A","5b1bC-4c0dA:2.5;5b1bJ-4c0dA:undetectable","5b1bC-4c0dA:14.62;5b1bJ-4c0dA:5.38"],["5B1B_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.85A","5b1bP-4c0dA:2.5;5b1bW-4c0dA:undetectable","5b1bP-4c0dA:14.62;5b1bW-4c0dA:5.38"],["5B1B_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.98A","5b1bP-4c0dA:2.5;5b1bW-4c0dA:undetectable","5b1bP-4c0dA:14.62;5b1bW-4c0dA:5.38"],["5DNV_A_BEZA304_0","SHKAI2IB","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A1882;HIS A1884;ILE A1888;TYR A1854","None","1.27A","5dnvA-4c0dA:undetectable","5dnvA-4c0dA:17.29"],["5KM8_B_L8PB201_1","HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 2, MITOCHONDRIAL;HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 2, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"ASN A2272;ALA A2271;GLN A2273;HIS A2114","None","1.03A","5km8A-4c0dA:undetectable;5km8B-4c0dA:undetectable","5km8A-4c0dA:11.81;5km8B-4c0dA:11.81"],["5M45_A_ACTA803_0","ACETONE CARBOXYLASE ALPHA SUBUNIT","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1;CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3","Homo sapiens;Homo sapiens",4,"GLU C 618;PRO A2087;ILE A2090;LEU A2091","None","1.21A","5m45A-4c0dC:undetectable","5m45A-4c0dC:12.31"],["5M45_D_ACTD803_0","ACETONE CARBOXYLASE ALPHA SUBUNIT","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1;CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3","Homo sapiens;Homo sapiens",4,"GLU C 618;PRO A2087;ILE A2090;LEU A2091","None","1.22A","5m45D-4c0dC:undetectable","5m45D-4c0dC:12.31"],["5M45_G_ACTG803_0","ACETONE CARBOXYLASE ALPHA SUBUNIT","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1;CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3","Homo sapiens;Homo sapiens",4,"GLU C 618;PRO A2087;ILE A2090;LEU A2091","None","1.21A","5m45G-4c0dC:undetectable","5m45G-4c0dC:12.31"],["5M45_J_ACTJ803_0","ACETONE CARBOXYLASE ALPHA SUBUNIT","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1;CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3","Homo sapiens;Homo sapiens",4,"GLU C 618;PRO A2087;ILE A2090;LEU A2091","None","1.26A","5m45J-4c0dC:undetectable","5m45J-4c0dC:12.31"],["5X1F_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3","Homo sapiens",4,"LEU C 671;PHE C 673;LEU C 666;PHE C 662","None","1.13A","5x1fC-4c0dC:undetectable;5x1fJ-4c0dC:undetectable","5x1fC-4c0dC:22.39;5x1fJ-4c0dC:15.33"],["5XOO_B_ADNB503_1","GLYCOSAMINOGLYCAN XYLOSYLKINASE","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1;CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 3","Homo sapiens",4,"LEU A2039;VAL A2035;GLU C 618;LEU A2091","None","1.03A","5xooB-4c0dA:undetectable","5xooB-4c0dA:6.88"],["5Y2O_A_8N6A501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",5,"PHE A2023;CYH A2020;PHE A2047;MET A2051;LEU A1967","None","1.22A","5y2oA-4c0dA:undetectable","5y2oA-4c0dA:7.40"],["5Z84_P_CHDP305_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","1.03A","5z84P-4c0dA:2.6;5z84W-4c0dA:undetectable","5z84P-4c0dA:14.62;5z84W-4c0dA:5.38"],["5Z85_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.94A","5z85C-4c0dA:2.5;5z85J-4c0dA:undetectable","5z85C-4c0dA:14.62;5z85J-4c0dA:5.38"],["5Z85_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","1.04A","5z85P-4c0dA:2.5;5z85W-4c0dA:undetectable","5z85P-4c0dA:14.62;5z85W-4c0dA:5.38"],["5Z86_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","1.00A","5z86C-4c0dA:2.6;5z86J-4c0dA:undetectable","5z86C-4c0dA:14.62;5z86J-4c0dA:5.38"],["5Z86_P_CHDP307_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","0.97A","5z86P-4c0dA:2.6;5z86W-4c0dA:undetectable","5z86P-4c0dA:14.62;5z86W-4c0dA:5.38"],["5ZCO_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.93A","5zcoC-4c0dA:2.5;5zcoJ-4c0dA:undetectable","5zcoC-4c0dA:14.62;5zcoJ-4c0dA:5.38"],["5ZCO_P_CHDP305_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","1.04A","5zcoP-4c0dA:4.3;5zcoW-4c0dA:undetectable","5zcoP-4c0dA:14.62;5zcoW-4c0dA:5.38"],["5ZCP_C_CHDC306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","1.06A","5zcpC-4c0dA:2.6;5zcpJ-4c0dA:undetectable","5zcpC-4c0dA:14.62;5zcpJ-4c0dA:5.38"],["5ZCP_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"GLN A2252;PHE A2251;LEU A2196;PHE A2192","None","1.07A","5zcpP-4c0dA:2.6;5zcpW-4c0dA:undetectable","5zcpP-4c0dA:14.62;5zcpW-4c0dA:5.38"],["5ZCQ_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",4,"LEU A1975;GLN A1976;LEU A2026;PHE A2034","None","0.94A","5zcqP-4c0dA:2.6;5zcqW-4c0dA:undetectable","5zcqP-4c0dA:14.62;5zcqW-4c0dA:5.38"],["6HUP_E_DZPE502_0","GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT ALPHA-1,GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT ALPHA-1;GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT BETA-3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",5,"LEU A2016;LEU A1963;THR A2022;ASN A2021;MET A2063","None","1.42A","6hupD-4c0dA:3.1;6hupE-4c0dA:2.6","6hupD-4c0dA:7.98;6hupE-4c0dA:7.50"],["6HUP_E_DZPE502_0","GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT ALPHA-1,GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT ALPHA-1;GAMMA-AMINOBUTYRIC ACID RECEPTOR SUBUNIT BETA-3","4c0d","CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1","Homo sapiens",5,"LEU A2016;LEU A1963;THR A2022;ASN A2021;PHE A2023","None","1.15A","6hupD-4c0dA:3.1;6hupE-4c0dA:2.6","6hupD-4c0dA:7.98;6hupE-4c0dA:7.50"]]